Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 14 (3) , 157-167
- https://doi.org/10.1016/s0885-3924(97)00020-1
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Morphine-6-glucuronide, a potent mu agonistPublished by Elsevier ,2002
- Mu receptor binding of some commonly used opioids and their metabolitesPublished by Elsevier ,2002
- Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain managementPain, 1995
- Opioid rotation for toxicity reduction in terminal cancer patientsJournal of Pain and Symptom Management, 1995
- Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotationJournal of Pain and Symptom Management, 1995
- Individual variability in the response to different opioids: report of five casesPain, 1992
- ANALGESIC EFFICACY AND CSF PHARMACOKINETICS OF INTRATHECAL MORPHINE-6-GLUCURONIDE: COMPARISON WITH MORPHINEBritish Journal of Anaesthesia, 1990
- Morphine-6-glucuronide: Analgesic effects and receptor binding profile in ratsLife Sciences, 1988
- Morphine‐6‐glucuronide Has High Affinity for the Opioid ReceptorBasic & Clinical Pharmacology & Toxicology, 1987
- Analgesic Effect of Morphine GlucuronidesThe Tohoku Journal of Experimental Medicine, 1971